Lymphoma

Showing NaN - NaN of 54

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Lymphoma Trial in United States (ABVD, BEACOPP, radiation therapy)

Completed
  • Lymphoma
  • Saint Helena, California
  • +54 more
Nov 5, 2021

Lymphoma Trial in United States (rituximab, bendamustine HCl, cyclophosphamide)

Completed
  • Lymphoma
  • rituximab
  • +8 more
  • Duarte, California
  • +203 more
Oct 14, 2021

Cancer, Adult Solid Tumor, Lymphoma Trial in United States

Recruiting
  • Cancer
  • +3 more
    • Birmingham, Alabama
    • +39 more
    Sep 28, 2021

    Lymphoma Trial in United States (ofatumumab)

    Completed
    • Lymphoma
    • ofatumumab
    • Lewes, Delaware
    • +47 more
    Aug 16, 2021

    Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

    Active, not recruiting
    • Leukemia
    • Lymphoma
    • rituximab
    • +7 more
    • Duarte, California
    • +24 more
    Aug 16, 2021

    Lymphoma Trial in United States (biological, drug, radiation, procedure)

    Completed
    • Lymphoma
    • Bleomycin Sulfate
    • +11 more
    • Tucson, Arizona
    • +94 more
    Jun 10, 2021

    Lymphoma Trial in United States (filgrastim, rituximab, carboplatin)

    Completed
    • Lymphoma
    • filgrastim
    • +8 more
    • Palo Alto, California
    • +103 more
    Oct 23, 2020

    Adult Solid Tumor, Lymphoma Trial in United States (Geriatric Assessment Summary, Geriatric Assessment Targeted Recommendations,

    Completed
    • Adult Solid Neoplasm
    • Lymphoma
    • Geriatric Assessment Summary
    • +2 more
    • Duarte, California
    • +18 more
    Oct 15, 2020

    Leukemia, Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

    Terminated
    • Leukemia
    • Lymphoma
    • therapeutic allogeneic lymphocytes
    • +8 more
    • Denver, Colorado
    • +22 more
    Apr 8, 2020

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Withdrawn
    • Leukemia
    • +4 more
    • alemtuzumab
    • +6 more
    • La Jolla, California
    • +23 more
    Nov 25, 2019

    Lymphoma Trial in United States (biological, drug, radiation)

    Completed
    • Lymphoma
    • rituximab
    • +5 more
    • Mobile, Alabama
    • +113 more
    Aug 15, 2019

    Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

    Completed
    • Lymphoma
    • Birmingham, Alabama
    • +175 more
    Jul 24, 2019

    Lymphoma Trial in United States (rituximab, bortezomib, cyclophosphamide)

    Completed
    • Lymphoma
    • rituximab
    • +5 more
    • Anchorage, Alaska
    • +146 more
    Oct 3, 2017

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )

    Completed
    • Chronic Myeloproliferative Disorders
    • +9 more
    • baclofen/amitriptyline/ketamine gel
    • placebo
    • Scottsdale, Arizona
    • +164 more
    Jul 25, 2017

    Lymphoma Trial in United States (denileukin diftitox, rituximab)

    Completed
    • Lymphoma
    • denileukin diftitox
    • rituximab
    • Scottsdale, Arizona
    • +164 more
    Mar 7, 2017

    Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in United States (biological, drug, other, procedure)

    Terminated
    • Leukemia
    • +5 more
    • anti-thymocyte globulin
    • +11 more
    • Lewes, Delaware
    • +9 more
    Feb 6, 2017

    Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )

    Completed
    • Chronic Myeloproliferative Disorders
    • +9 more
    • American ginseng
    • placebo
    • Scottsdale, Arizona
    • +325 more
    Dec 19, 2016

    Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)

    Completed
    • Cachexia
    • +3 more
    • Juven
    • Non-Juven Supplement
    • Birmingham, Alabama
    • +249 more
    Dec 6, 2016

    Leukemia, Lymphoma Trial in United States (filgrastim, rituximab, cyclophosphamide)

    Completed
    • Leukemia
    • Lymphoma
    • filgrastim
    • +12 more
    • San Diego, California
    • +30 more
    Jul 1, 2016